Endo Pharmaceuticals recalls Robaxin 750mg tablets due to incorrect dosage instructions on labels. This could lead to unsafe dosing if users follow the wrong label instructions.
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Take action
Contact the company
📍Recalling firmEndo Pharmaceuticals, Inc.1400 Atwater Dr · Malvern, PA 19355-8701
✎ GovInfoNow plain-language explainer
Endo Pharmaceuticals is recalling Robaxin 750mg tablets because the label incorrectly states "two to four tablets four times daily" instead of "two tablets three times daily." This could lead to taking too many pills and potential overdose risk. Read more at govinfonow.com/recall/39564-endo-robaxin-750mg-tablets-incorrect-dosage-label-recall.
“Endo Robaxin 750mg Tablets: Incorrect Dosage Label Recall.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39564-endo-robaxin-750mg-tablets-incorrect-dosage-label-recall. Based on FDA recall #D-0009-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2019%22&limit=1).
Endo Pharmaceuticals, Inc. recalled robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottles due to incorrect dosage instructions on the label, according to the FDA. The Food and Drug Administration announced the Class I recall on September 17, 2018.
Lot codes: 216702P1 (Exp 09/20) and 220409P1 (Exp 01/21)
Quantity: 2,856 bottles
The hazard
The immediate container label incorrectly states the dosage as "Two to four tablets four times daily" instead of the correct "Two tablets three times daily." The FDA classified this labeling error as a Class I recall.
Context
GovInfoNow's records show Endo Pharmaceuticals, Inc. has had four other recalls since May 7, 2012. Other recent recalls of similar products include Greenstone Methylprednisolone Tablets Recall (January 15, 2026), Alvogen Thyro-Tabs 150mcg Tablets Recall (December 31, 2025), and American Regent Levocarnitine Injection Recall (April 16, 2026).
How to tell if you have this one
Check for Robaxin 750mg tablets with lot numbers 216702P1 (expiring September 2020) or 220409P1 (expiring January 2021). The product is only available by prescription.
Brand
Endo Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label Instructions
Review the dosage instructions on the label to ensure they match the correct dosage of two tablets three times daily.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0009-2019 (September 17, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0009-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.